2020
DOI: 10.1111/ejh.13413
|View full text |Cite
|
Sign up to set email alerts
|

Mixed phenotype acute leukemia: Biological profile, clinical characteristic and treatment outcomes: Report of the population‐based study

Abstract: Objectives The aim of this population‐based, retrospective study was to analyze biological and clinical features and treatment results in children diagnosed with MPAL in all Polish pediatric oncology centers between 2007 and 2018. Methods Among 2893 children and adolescents diagnosed and treated for acute leukemia, 39 (1.35%) patients fulfilled the WHO criteria of MPAL. The T/myeloid phenotype was most prevalent. Results Cytogenetics findings were seen in 2 (5.1%), while chromosomal abnormalities were found in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…Among 28 children treated for a MPAL with lymphoid-type treatment between 1996 and 2006 in the Czech Republic, 3 had a KMT2A/ AFF1 rearrangement, only one being alive after HSCT in CR2 (1). In a more recent series of 39 pediatric MPAL cases treated in Poland from 2007 to 2018, four cases presented with a KMT2A rearrangement but no details are provided regarding their specific treatment and outcome (7). An international cooperative study (18 centers participating in the iBFM-AMBI2012 study) looked at the therapeutic strategies and the outcome of 233 children with ambiguous lineage acute leukemia (ALAL) between 2002 and 2015 (176 single-population ALAL, 45 bilineal ALAL, 12 undifferentiated).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Among 28 children treated for a MPAL with lymphoid-type treatment between 1996 and 2006 in the Czech Republic, 3 had a KMT2A/ AFF1 rearrangement, only one being alive after HSCT in CR2 (1). In a more recent series of 39 pediatric MPAL cases treated in Poland from 2007 to 2018, four cases presented with a KMT2A rearrangement but no details are provided regarding their specific treatment and outcome (7). An international cooperative study (18 centers participating in the iBFM-AMBI2012 study) looked at the therapeutic strategies and the outcome of 233 children with ambiguous lineage acute leukemia (ALAL) between 2002 and 2015 (176 single-population ALAL, 45 bilineal ALAL, 12 undifferentiated).…”
Section: Discussionmentioning
confidence: 99%
“…Lineage switch (B to M or vice versa) or persistence of only the lymphoid or myeloid clone is frequently observed in biphenotypic/bilineal cases, highlighting their lineage plasticity. Prognosis of MPAL remains bleak, with an event-free survival (EFS) of less than 50% in children (1,(5)(6)(7). A lymphoid-type therapeutic approach appears to be more effective (6, 7) but failures to achieve complete remission (CR) remain significant.…”
Section: Introductionmentioning
confidence: 99%
“…Patients treated with an ALL approach appear to be less likely to relapse than patients treated with an AML therapy approach. In addition, the remission durations of relapsed patients tend to be shorter, while age, lineage switch, and higher white counts are not predictive of worse outcomes per se [ 60 ].…”
Section: Role Of Hematopoietic Stem Cell Transplantationmentioning
confidence: 99%